首页|期刊导航|药物分析学报(英文)|CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability
药物分析学报(英文)2026,Vol.16Issue(2):359-376,18.DOI:10.1016/j.jpha.2025.101357
CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability
CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability
摘要
关键词
CRISPR-Cas/Gene editing/Targets identification/Drug discoveryKey words
CRISPR-Cas/Gene editing/Targets identification/Drug discovery引用本文复制引用
Yao He,Xiao Tu,Yuxin Xue,Yuxuan Chen,Bengui Ye,Xiaojie Li,Dapeng Li,Zhihui Zhong,Qixing Zhong..CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability[J].药物分析学报(英文),2026,16(2):359-376,18.基金项目
This project was supported by National Natural Science Foun-dation of China(Grant No.:82071349),Sichuan Science and Technology Program,China(Grant No.:2025ZNSFSC0703),Young Scientists Fund of the National Natural Science Foundation of China(Grant No.:82204513),Natural Science Foundation of Sichuan Province,China(Grant No.:2023NSFSC1673),Innovation Guidance Foundation of the Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province,China(Grant No.:SCU2023D005),and Scientific Research Staring Foundation of Sichuan University,China(Grant No.:YJ202165).The authors would like to thank Sichuan Junhui Biotechnology Co.,Ltd.and Singapore HumanSim Pte.Ltd.for helping this study. (Grant No.:82071349)